{
    "answer": "For Cosentyx's net sales in the immunology segment:\n*   Full year 2024: $13 billion (USD), +10% (const. cur. cc) compared to the full year 2023.\n*   Full year 2023: $19 billion (USD) compared to the full year 2024.\nSpecific reports are in the supplementary financial data reports retrieved directly from Novartis.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 8,
    "search count": 7,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        873,
        2711,
        3509,
        4340,
        5224,
        5701,
        7361,
        9244
    ]
}